[HTML][HTML] Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin
FS Hodi, CL Corless, A Giobbie-Hurder… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
FS Hodi, CL Corless, A Giobbie-Hurder, JA Fletcher, M Zhu, A Marino-Enriquez…
Journal of clinical oncology, 2013•ncbi.nlm.nih.govImatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal,
Acral, and Chronically Sun-Damaged Skin - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J Clin
Oncol PMC4878082 Other Formats PubReader PDF (1.5M) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases …
Acral, and Chronically Sun-Damaged Skin - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J Clin
Oncol PMC4878082 Other Formats PubReader PDF (1.5M) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI Databases …
Abstract
Purpose
Amplifications and mutations in the KIT proto-oncogene in subsets of melanomas provide therapeutic opportunities.
ncbi.nlm.nih.gov